Clinical Trials Directory

Trials / Completed

CompletedNCT06795594

Effectiveness of Cheek Acupuncture Therapy for Pain Control After Cesarean Delivery

Cheek Acupuncture Therapy Vs. Standard Therapy for Pain Control After Elective Caesarean Section - a Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Beijing Tongren Hospital · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

This study investigates whether cheek acupuncture therapy can alleviate postoperative pain in cesarean section patients and explores its mechanisms of action through a prospective randomized controlled clinical trial.

Detailed description

Pain control after cesarean delivery, if inadequately managed, can impact the prognosis of the mother and the health of the infant. There is an urgent need to explore safer, more effective, and straightforward non-pharmacological adjunctive interventions to alleviate the pain associated with cesarean section. Cheek acupuncture therapy is a green micro-acupuncture treatment that has shown significant improvement in various types of pain and holds great potential for relieving perioperative pain. To practice the concept of perioperative acupuncture medicine, this study aims to investigate whether cheek acupuncture therapy can alleviate postoperative pain in cesarean section patients and to explore the mechanisms by which it exerts its effects, through a prospective randomized controlled clinical trial.

Conditions

Interventions

TypeNameDescription
PROCEDUREcheek acupunctureCheek Acupuncture
DRUGsufentanil 2 µg/kg + ondansetron 0.2 mg/kgThe patient-controlled analgesia (PCA) pump held a solution of 2 µg/kg sufentanil and 0.2 mg/kg ondansetron in 100 ml. It infused 2 ml/hour continuously, allowing patients to self-administer an extra 2 ml bolus every 15 minutes if needed. For inadequate pain control, diclofenac sodium suppositories were used as rescue analgesia, depending on individual pain assessments and the requirement for extra relief.

Timeline

Start date
2025-01-05
Primary completion
2025-03-10
Completion
2025-03-10
First posted
2025-01-28
Last updated
2025-03-25

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06795594. Inclusion in this directory is not an endorsement.